The heart attack that runs in your family did not consult a reference range and neither did the cholesterol that looked fine on every standard panel. A standalone Lp(a) test cost without insurance commonly runs from roughly $50 to $150 as a cash-pay draw, depending on the lab and the assay. Lp(a) is the inherited lipoprotein that standard lipid panels never measure. One draw can change how every future cardiovascular decision gets made. Insurance coverage is inconsistent because many plans still classify the test as a specialty test.

At GoodLife Health the number is not a product. One comprehensive Biomarker Audit every 90 days, four per year, is included in the $299 per month Cardiometabolic Optimization Membership, with Lp(a) and ApoB both on the panel alongside the clinician who reads them together. Here is what the test is for, what it costs on the open market and what the membership actually buys.

Key Takeaways
  • A standalone cash-pay Lp(a) test commonly costs from roughly $50 to $150, varying by lab and assay.
  • Many insurance plans still do not cover Lp(a) testing routinely, which is why it is often missing from standard panels.
  • The Biomarker Audit includes Lp(a) and ApoB on the same draw, repeated every 90 days, inside the $299 monthly membership.
  • Lp(a) is largely inherited, so it is usually measured once and then used to set your lifetime risk context.

What Lp(a) is and why the standard panel misses it

Lp(a), spoken aloud as lipoprotein little a, is an LDL-like particle with an extra protein attached. It travels in the blood, enters the artery wall like other atherogenic particles and is set almost entirely by genetics rather than by diet or exercise. Most adults have never been tested for it, because a standard lipid panel reports total cholesterol, LDL, HDL and triglycerides and Lp(a) hides inside the LDL number without being identified.

The clinical case for testing it comes down to lifetime risk. A person with LDL of 110 mg/dL and elevated Lp(a) carries meaningfully different cardiovascular risk from a person with the same LDL and low Lp(a) and the two should be managed differently. Guidelines from lipid societies have moved toward measuring Lp(a) at least once in adulthood for exactly that reason and the Family Heart Foundation, a patient advocacy group focused on the marker, exists because so many people discover it only after a cardiac event in the family.

What it costs on the open market

Pricing varies by lab, region and assay method, so treat these as commonly reported ranges rather than quotes. Direct-to-consumer lab platforms commonly list Lp(a) from roughly $50 to $100 as a standalone add-on. Comprehensive panels that include it alongside ApoB and advanced lipid testing commonly run from around $100 to $300 total. Insurance coverage is the inconsistent part. Some plans cover it when there is a documented family history of early heart disease and others classify it as investigational, which leaves the patient with the full cash price and a denial letter.

Two structural notes matter more than the sticker. First, the assay itself comes in two units, mg/dL and nmol/L and the cutoffs differ, so the same blood at two labs can print different numbers. Trends should always be followed within one lab's method. Second, Lp(a) is usually drawn once and interpreted for life. The value that repeats every 90 days is ApoB and the rest of the panel, with Lp(a) as the fixed context those trends are read against.

What the numbers show
$50 to $150
Commonly reported standalone cash price for an Lp(a) draw
Once
How often Lp(a) usually needs to be measured to set lifetime risk
Every 90 days
How often the full Biomarker Audit repeats inside the membership

Why the draw alone is not the decision

Suppose you buy the $75 draw and the result comes back elevated. What happens next? In the standard system the answer is usually a referral, a wait and a conversation with a clinician who has fifteen minutes and has never seen your other numbers. An elevated Lp(a) changes how aggressively every other marker should be managed, which means it changes your ApoB target, your follow-up cadence and sometimes the medication conversation. Those decisions require a clinician who holds the whole panel and your history, not a PDF.

That is also why we fold the test into a cadence rather than selling it once. When Lp(a) is known and elevated, the response is to manage the modifiable markers around it, ApoB first, with the audit's trend line as the evidence. When it is normal, it still belongs on the panel once so the interpretation of every future lipid result is correct. Either way the value comes from the reading and the reading is the part the flat fee buys.

Direct primary care is the model that makes this possible and the American Academy of Family Physicians describes it as a flat periodic fee covering defined clinical services with no fee-for-service billing. When testing is included rather than itemized, the incentive is to order it exactly when it changes a decision.

GoodLife Health. Labs, clinician, medicine, platform, $299 a month: quarterly labs, your clinician, guided GLP-1s, your data in one place. Check eligibility.GoodLife Health. Your labs, your clinician, your medicine, your data. One place. Comprehensive labs every 90 days, a board-certified clinician, branded GLP-1s when indicated, and a platform that holds it all, $299 a month. Check your eligibility.

What the $299 membership includes

The membership is $299 a month, month to month after a two-month start. The fee covers clinicians licensed in all fifty states, four Biomarker Audits a year with Lp(a), ApoB, hs-CRP, HbA1c, lipids, insulin markers and full hormone and thyroid panels, every result in your hands, asynchronous messaging with the care team and video visits. There are no tiers and the fee is the same whatever is prescribed and whatever the dose.

Medication is unbundled. When treatment is clinically indicated, your clinician sends the prescription to the pharmacy you choose and the pharmacy bills you at its own price. GoodLife Health sets nothing, sees nothing and takes nothing on that transaction. One flat fee pays for the doctor and the pharmacy bills the medicine at cost.

The $598 first charge covers the first two months and the first audit. It is held at sign-up and charged only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once accepted, the first two months are charged and non-refundable.

The offer, plainly

The membership is $299 a month with a two-month start: $598 for the first two months, held at sign-up and charged only once a clinician accepts you. Four full Biomarker Audits a year, Lp(a) included and the clinical relationship around them. Medication is billed separately by the pharmacy at pharmacy cost with zero markup.

Who this is for and who it is not for

This is for the reader with early heart disease in the family who has been told their cholesterol is fine and suspects the panel was incomplete. It suits the person who wants the inherited marker drawn once, correctly and then wants the modifiable markers tracked by someone accountable for the plan.

It is not for someone who wants a single lab slip. It is not for anyone outside the United States, because our clinicians are licensed in the fifty states. And it is not insurance. The membership pairs with insurance for catastrophic coverage and replaces the primary-care relationship, not the policy.

FAQ

How much does an Lp(a) test cost without insurance?

As a standalone cash-pay draw it commonly runs from roughly $50 to $150 depending on the lab and assay and comprehensive panels that include it with advanced lipid testing commonly run $100 to $300 total. GoodLife Health includes Lp(a) in the Biomarker Audit that repeats every 90 days inside the $299 monthly membership.

Does insurance cover Lp(a) testing?

Sometimes. Some plans cover it with a documented family history of early heart disease and others classify it as investigational, so coverage is never promised. The membership itself is not billed to insurance, so the plan question applies to standalone draws rather than to the included audit.

How often should Lp(a) be measured?

Most guidance treats it as a once-in-adulthood measurement because it is largely inherited and stable across life. What changes over time is ApoB and the other modifiable markers, which is what the quarterly audit tracks.

What does a high Lp(a) mean?

It means your inherited cardiovascular risk floor is higher than a standard panel suggests and that the modifiable markers around it, especially ApoB and blood pressure, should be managed more tightly. A clinician reading your full panel sets what that means in practice for you.

Is Lp(a) included in the membership's panel?

Yes. The Biomarker Audit includes Lp(a) alongside ApoB, hs-CRP, HbA1c, lipids, insulin markers and full hormone and thyroid panels, four times a year, inside the flat $299 fee. Additional labs beyond that cadence are ordered for a clinical reason and billed at pass-through cost.

Can I just buy the Lp(a) test once without joining?

Yes, direct-to-consumer labs sell it. What you do not get is a clinician who reads it against your history and adjusts the rest of your cardiovascular management because of it. That reading is the part that changes outcomes and it is what the membership fee covers.

Is this available outside the United States?

No. Our clinicians are licensed to practice in the fifty states and the membership serves United States residents only. Readers elsewhere deserve that answer stated plainly.

One last thing

Most people will spend more on one specialist copay than on the entire testing question and still never learn their Lp(a). If early heart disease runs in your family, the cheapest useful hour of your year is the one where someone draws it and tells you what it means. If you want that reader to be the same clinician who manages the numbers afterward, the eligibility check is free, takes a few minutes and never results in a charge unless a clinician accepts you into care.

Related Guides

References

  1. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
  2. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/